Breaking ground: CSHL President & CEO Bruce Stillman; ESD Long Island Regional Director Andrea Lohneiss; NY State Assemblyman Charles Lavine; Long Island Association President and Regional Council Co-Chair Kevin Law
Cold Spring Harbor Laboratory (CSHL), a preeminent international research institution, achieving breakthroughs in molecular biology and genetics and enhancing scientific knowledge worldwide, and the Long Island Regional Economic Development Council (LIREDC) joined with State and local elected officials to break ground on CSHL’s Preclinical Experimental Therapeutics Facility in Woodbury, Nassau County. The project, which is moving forward on the strength of a $2 million award from Governor Andrew M. Cuomo’s Regional Council initiative, will significantly advance CSHL’s Cancer Therapeutic Initiative for cancer research by establishing an advanced drug testing facility and result in the creation of 30 new jobs on Long Island.
Governor Cuomo praised the initiative. "This expansion project demonstrates how Long Island is becoming a leading hub for scientific and medical study," Governor Cuomo said. "With the support of the Regional Council Initiative, Cold Spring Harbor Laboratory is moving forward with a facility that will enable critical research seeking to advance the quality of healthcare around the globe. I am pleased that the project is now underway, and look forward to seeing its positive impact on the region for years to come.
Dr. Bruce Stillman, President & CEO, Cold Spring Harbor Laboratory said, “With this new facility we want to maximize the impact of what an academic institution like CSHL does best: discover targets for new cancer therapies based on our deep knowledge of cancer biology. The Cancer Therapeutics Initiative aims to deliver well-validated drug candidates to industry. Industry can then focus on what it does best: optimizing candidate molecules and testing them in cancer patients. CSHL envisions collaboration with other research and clinical centers as well as biotech and pharmaceutical companies that can both contribute to and benefit from the vertically integrated CTI pipeline.”
LIREDC Co-chairs Kevin Law, President, Long Island Association and Stuart Rabinowitz, President, Hofstra University said, “This groundbreaking is a major milestone not only for Cold Spring Harbor Laboratory and Long Island, but also for the critical research CSHL conducts to find new and innovative ways to treat cancer and improve the quality of life for people around the world. This project was identified as a priority by the Council in 2011 because it creates jobs, spurs economic development and advances the health and technology industry on Long Island. We congratulate Dr. Stillman and all of CSHL’s current – and future – employees, and look forward to seeing the completion of this important new facility.”
Cold Spring Harbor Laboratory is a private, non-profit institution with research programs focusing on cancer, neurobiology, plant genetics, genomics and bioinformatics. CSHL currently employs over 600 scientists and over its history has had eight Nobel laureates work at the laboratory. The first human cancer gene was discovered at CSHL and many key findings on genetic mechanisms and pathways of cancer have been made at the Laboratory. The project, part of CSHL’s Cancer Therapeutic Initiative, consists of the construction of the Preclinical Experimental Therapeutics Facility, an advanced drug testing facility for cancers including lung, liver, pancreatic, brain, prostate and breast cancers as well as melanoma and leukemia. The facility will be located at CSHL’s Woodbury campus in Nassau County.
In Round 1 of the Regional Council initiative, the Preclinical Experimental Therapeutics Facility was deemed transformative by the Long Island Regional Economic Development Council and endorsed as a Priority Project, receiving the full backing of the Council. As a result, CSHL was awarded $2 million in performance-based incentives from Empire State Development to assist in establishing an advanced drug testing facility. ESD’s funding is supporting a portion of the $15 million project, which will result in the creation of 30 new jobs at the project location and the retention of more than 900 employees.
Empire State Development President, CEO & Commissioner Kenneth Adams said, “New York State is pleased to assist Cold Spring Harbor Laboratory’s advanced testing facility, helping to support its transformational research and development work and further grow the biotech cluster on Long Island. CSHL’s new $15 million facility will not only allow this premier research institute to expand its capacity in cancer research, but will also create more than two dozen new, high paying jobs.”
CSHL has consistently been rated #1 in the world by Thompson Reuters for its impact on molecular biology over the last ten years; it is one of sixty-three institutions supported by the Cancer Centers Program of the National Cancer Institute (NCI); and has been a NCI-designated cancer center since 1987.
About the Regional Economic Development Councils
The Regional Economic Development Council initiative is a key component of Governor Andrew M. Cuomo’s transformative approach to State investment and economic development. The Councils are public-private partnerships composed of local experts and stakeholders from business, academia, local government, and non-governmental organizations. The Regional Councils have redefined the way New York invests in jobs and economic growth by putting in place a community-based, bottom up approach and establishing a competitive process for State resources. As a result of the first two rounds of awards, $1.5 billion in resources have been awarded to support more than 1,400 regionally significant economic development and community revitalization projects that are creating or helping to retain an estimated 75,000 jobs across the Empire State and generating investments to grow the economy.
About Cold Spring Harbor Laboratory
Founded in 1890, Cold Spring Harbor Laboratory (CSHL) has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. CSHL is ranked number one in the world by Thomson Reuters for the impact of its research in molecular biology and genetics. The Laboratory has been home to eight Nobel Prize winners. Today, CSHL's multidisciplinary scientific community is more than 600 researchers and technicians strong and its Meetings & Courses program hosts more than 12,000 scientists from around the world each year to its Long Island campus and its China center. Tens of thousands more benefit from the research, reviews, and ideas published in journals and books distributed internationally by CSHL Press. The Laboratory's education arm also includes a graduate school and programs for middle and high school students and teachers. CSHL is a private, not-for-profit institution on the north shore of Long Island. For more information, visit www.cshl.edu.